Skip to main content
Elsevier
View Cart
My account

Books in Clinical trials

BooksJournals

    • A Comprehensive Guide for Novice Researcher in Clinical Trials

      • 1st Edition
      • March 1, 2026
      • Miltiadis Lytras + 2 more
      • English
      A Comprehensive Guide for Novice Researcher in Clinical Trials serves as an essential resource for anyone looking to navigate the complex world of clinical trials. Designed specifically for novice research enthusiasts, this book provides a thorough introduction to the principles, training, and skills necessary for designing and conducting clinical trials. Spanning 13 detailed chapters, it covers the entire spectrum of clinical trial methodology while adhering to Good Clinical Practice (GCP) standards. The book begins with foundational concepts in health research methods and clinical epidemiology, laying the groundwork for understanding the significance and necessity of clinical trials in healthcare. It explores various research designs, types of bias, and the historical context that shaped modern clinical trial practices. In-depth discussions on clinical trial design, including parallel, crossover, and adaptive designs, equip readers with the knowledge to select the appropriate framework for their research. Essential sections on ethics, regulatory requirements, and protocol development ensure that researchers understand the critical responsibilities involved in conducting ethical and scientifically sound trials. The guide also delves into practical aspects such as clinical data management, monitoring, and statistical principles, empowering readers to manage data effectively and analyze results accurately. With insights into project management and regulatory affairs specific to clinical trials in Saudi Arabia, the book addresses local challenges and requirements, making it particularly relevant for health professionals in the region. By providing a stepwise approach to clinical trial conduction, this book aims to promote better access, understanding, and utilization of clinical trials within diverse health disciplines. With its comprehensive coverage and up-to-date information, Clinical Trials: A Comprehensive Guide for Novice Researchers not only equips readers with the necessary tools to enhance their research capabilities but also contributes to the overall improvement of healthcare delivery and patient outcomes globally.

    • Fundamentals of Biologicals Regulation

      • 2nd Edition
      • November 1, 2025
      • Rebecca Sheets + 6 more
      • English
      • Paperback
        9 7 8 0 4 4 3 2 1 9 8 8 7
      • eBook
        9 7 8 0 4 4 3 2 1 9 8 9 4
      Fundamentals of Biologicals Regulation: Vaccines and Biotechnology Medicines, Second Edition serves as an introduction to the international regulatory arena in which biologicals are developed, offering an overview of processes and insights into the scientific concepts underpinning global regulations. The book provides in-depth coverage of Quality by Design, Combination Products, Quality Target Product Profiles, Risk Management Plans, REMS, and switching from reliance on in vivo to in vitro analytical methods. It reflects new developments and processes accelerated by the COVID-19 vaccine experience, including emergency use authorizations and conditional marking authorizations. New pedagogic elements and case studies have been added to improve learning outcomes.This book provides multiple levels of readership, with guidance on basic concepts, a detailed look at regulatory challenges, and practical insights into how regulators consider regulatory science and regulatory process issues across various regions, with an emphasis on the European Medicines Agency and the U.S. Food and Drug Administration.

    • Handbook of Intervention Science

      • 1st Edition
      • September 9, 2025
      • Laura N.Gitlin + 1 more
      • English
      • Paperback
        9 7 8 0 4 4 3 2 1 6 6 4 0
      • eBook
        9 7 8 0 4 4 3 2 1 6 6 5 7
      Handbook of Intervention Science: From Design to Implementation discusses multiple approaches for developing and advancing interventions at the individual, family, community, health system, and policy level. The book focuses on creating interventions suitable for diverse populations from racial, ethnical, geographical, and socioeconomical perspectives. Combining best practices with a practical approach, the book enables readers to advance their intervention research. It covers intervention design, data capture in trials, and evaluation. Decision trees help illustrate when to move forward with an implementation relative to the need for further work.

    • Quality Assurance Management

      • 1st Edition
      • July 20, 2024
      • Gayathri De Lanerolle + 3 more
      • English
      • Paperback
        9 7 8 0 1 2 8 2 2 7 3 2 9
      • eBook
        9 7 8 0 1 2 8 2 2 7 3 3 6
      Quality Assurance Management: A Comprehensive Overview of Real-World Applications for High Risk Specialties demonstrates how to best design and implement standard operating procedures (SOPs) to ensure protocol and regulation adherence. The book showcases similarities and differences between healthcare and academic quality assurance systems, resulting in counter-productivity and performance issues, in addition to regulatory inspection preparedness. It uses the processes and standards of the UK to demonstrate how to combine QA and research building into ‘building blocks’ that share a common pathway for effective project design, analysis and unbiased interpretation of collated data.This book fills a gap, providing original research in QA that especially focuses on specialist areas. It will be of use to research and clinical staff working in clinical research within healthcare, academia and industry.

    • Essentials of Translational Pediatric Drug Development

      • 1st Edition
      • July 22, 2024
      • Elke Gasthuys + 3 more
      • English
      • Paperback
        9 7 8 0 3 2 3 8 8 4 5 9 4
      • eBook
        9 7 8 0 3 2 3 9 0 4 2 9 2
      Essentials of Translational Pediatric Drug Development: From Past Needs to Future Opportunities provides integrated and up-to-date insights relevant for both translational researchers and clinicians active in the field of pediatric drug development. The book covers all key aspects from different stakeholder perspectives, providing a literature overview and careful reflection on state-of-the-art approaches. It will be an ideal guide for researchers in the field who are designing and performing high quality, innovative pediatric-adapted drug development by helping them define needs/challenges and possible solutions that advance and harmonize pediatric drug development.Despite the broad consensus that children merit the same quality of drug treatment as any other age group, children remain frequently neglected during drug research and development. Even with the adoption of multiple legislations addressing this problem, the lack of efficacy and safety data of marketed as well as newly developed drugs still remain in the pediatric population.

    • Clinical Trials and Tribulations

      • 1st Edition
      • March 1, 2023
      • Gayathri De Lanerolle + 2 more
      • English
      • Paperback
        9 7 8 0 1 2 8 2 1 7 8 7 0
      • eBook
        9 7 8 0 1 2 8 2 1 7 8 8 7
      Clinical Trials and Tribulations evaluates the multiple layers of complexities around research management, also exploring current practices, challenges and future directions. The book provides answers to readers questions and problems through extensive use of real-world examples, case studies and lessons learned. Following an approach to provide pragmatic viewpoints as well as concepts and methodologies and its alignment with specific practices, the book explores paradigms between planning and conducting research in academia vs. healthcare vs. industry in the UK vs. Europe vs. America. It highlights practical solutions to real-world complex issues that have been documented by independent regulators. This will be an indispensable book for all staff working in clinical research within healthcare, academia and industry, as well as students intending to work in clinical trials.

    • Practical Biostatistics

      • 2nd Edition
      • June 4, 2021
      • Mendel Suchmacher + 1 more
      • English
      • Paperback
        9 7 8 0 3 2 3 9 0 1 0 2 4
      • eBook
        9 7 8 0 3 2 3 8 9 8 9 7 3
      Practical Biostatistics: A Step-by-Step Approach for Evidence-Based Medicine, Second Edition presents a complete resource of biostatistical knowledge meant for health sciences students, researchers and health care professionals. The book's content covers the investigator’s hypothesis, collective health, observational studies, the biostatistics of intervention studies, clinical trials and additional concepts. Chapters are written in a didactic way, making them easier to comprehend by readers with little or no background on statistics. Evidence-based medicine aims to apply the best available evidence gained from the scientific method to medical decision-making using statistical analyses of scientific methods and outcomes to drive further experimentation and diagnosis. With a detailed outline of implementation steps complemented by a review of important topics, this book can be used as a quick reference or hands-on guide on how to effectively incorporate biostatistics in clinical trials and research projects.

    • Considering the Patient in Pediatric Drug Development

      • 1st Edition
      • November 19, 2020
      • Klaus Rose
      • English
      • Paperback
        9 7 8 0 1 2 8 2 3 8 8 8 2
      • eBook
        9 7 8 0 1 2 8 2 4 2 0 5 6
      Considering the Patient in Pediatric Drug Development: How Good Intentions Turned into Harm addresses a fundamental challenge in drug development and healthcare for young patients. In clinical trials and clinical practice, the term "children" is used ambiguously to confer physiological characteristics to a chronological age limit, which in reality does not exist. This book outlines why the United States (US) and European Union's (EU) regulatory authorities, pediatric academia, and the pharmaceutical industry demand, support and perform pediatric drug studies, along with the key flaws of this demand that blurs the different administrative and physiological meanings of the term "child." In addition, the book covers why most pediatric regulatory studies lack medical sense and many even harm young patients and the conflicts of interest behind pediatric drug studies. It includes relevant information about the maturation of the human body regarding absorption, distribution, metabolism and excretion of food and drugs as well as key differences between newborns, infants, older children and adolescents.

    • Innovation in Clinical Trial Methodologies

      • 1st Edition
      • November 1, 2020
      • Peter Schueler
      • English
      • Paperback
        9 7 8 0 1 2 8 2 4 4 9 0 6
      • eBook
        9 7 8 0 3 2 3 8 6 0 0 6 2
      Innovation in Clinical Trial Methodologies: Lessons Learned during the Corona Pandemic presents a selection of updated chapters from Re-Engineering Clinical Trials that feature innovative options and methods in clinical trials. The Coronavirus pandemic is an accelerator for digitalization in many industries, including clinical trials. This book considers best practices, alternative study concepts requiring fewer patients, studies with less patient interaction, the design of "virtualized" protocols, and moving from data to decisions. This book will be helpful to pharmacologists, physicians and clinical researchers involved in the process of clinical development and clinical trial design.

    • Pregnancy and the Pharmaceutical Industry

      • 1st Edition
      • May 24, 2019
      • Kristine E. Shields
      • English
      • Paperback
        9 7 8 0 1 2 8 1 8 5 5 0 6
      • eBook
        9 7 8 0 1 2 8 1 9 0 7 4 6
      Pregnancy and the Pharmaceutical Industry: The Movement towards Evidence-Based Care for Pregnant Women explores the issues surrounding the decision to undertake clinical trials with pregnant women. There is currently a lack of data on the safety and effectiveness of medications used during pregnancy as it is impossible to extrapolate that information from drug studies on men and non-pregnant women. As a majority of pregnant women confront a medical condition during their pregnancy, from simple pain, to ongoing or new medical issues, this book quantifies the current absence of pregnant women in drug studies and identifies ethical issues, barriers, litigation fears and opportunities. Those in the pharmaceutical industry, IRB members who approve or deny drug study plans, doctors, nurses and midwives working in obstetrics or involved in conducting studies at their institutions will find this book an essential resource.